Abstract A series of 2-aminosubstituted (5Z)-3-phenyl-5-(pyridine-2-ylmethylene)-3,5-dihydro-4 H-imidazole-4-ones (L) was prepared by the reaction of the corresponding 2-alkylthio-3,5-dihy dro-4H-imidazole-4-ones with morpholine or piperidine in the presence of ytterbium(III) triflate. The resulting ligands were subsequently reacted with CuCl 2 Á2H 2 O and CoCl 2 Á6H 2 O to give the corresponding copper(II) and cobalt(II) complexes, respectively. Analysis revealed that the complexes were formed with an LMCl 2 (M = Cu, Co)-type composition in all cases. The structures of the three cobalt complexes prepared in this way were determined by X-ray crystallography. The results revealed that the cobalt ions in these complexes were tetrahedrally coordinated to two chloride anions and two nitrogen atoms from the pyridine and imidazole moieties of the ligand. The electrochemical properties of the ligands and their complexes were evaluated by cyclic voltammetry, and the results revealed that the first stage in the reduction of the Co(II) and Cu(II) complexes involved the reversible formation of the corresponding Co(I) and Cu(I) complexes, respectively. The cytotoxicity activities of the organic ligands and their complexes were evaluated against several cancer cell lines, including MCF-7, A549 and HEK293 cells. The copper complexes of the organic ligands bearing a phenyl or allyl moiety at their N(3) position together with a piperidine substituent at the 2-position of their imidazolone ring exhibited the greatest cytotoxicity of all of the compounds tested in the current study.
Despite its high neuro-and nephrotoxicity, cisplatin is still one the most commonly used anticancer drugs in clinical practice (Anderson et al., 1990; Ries and Klastersky, 1986) . In contrast to platinum, copper is an endogenous metal that is necessary for normal cellular activity. For example, copper is found in several important enzymes, including eukaryotic copper amine oxidase (Parsons et al., 1995) , NO-reductase (Gardner et al., 2002; Oshima et al., 2005) and superoxide dismutase (Konecny et al., 1999; Tainer and Getzoff, 1982) . It is therefore envisaged that copper complexes will be less toxic than the corresponding platinum-based anticancer compounds (Du et al., 2014) . Bisthiosemicarbazone (Williams and Faulkner, 1996) , phenanthroline (Sharma et al., 1980; de Vizcaya-Ruiz et al., 2000) and several other (Santini et al., 2014) copper complexes have been reported to show high levels of cytotoxicity against numerous cancer cell lines, and some of these complexes are currently being evaluated in clinical trials (Kang et al., 2009; Pickart, 2008) .
We recently discovered a series of cytotoxic copper complexes based on 2-thiohydantoin derivatives, namely (5Z)-(5-pyridylmethy lene)-2-alkylthioimidazole-4-ones (Majouga et al., 2014) . These complexes exhibited cytotoxic activity against several cancer cell lines, including HEK-293 (transformed human embryonic kidney), SiHa (cervical cancer) and MCF-7 (breast cancer) cells. It has been reported that 2-thiohydantoin-containing complexes are one of very few classes of copper complex that can be visualized in cell nuclei in their nondissociated form (Majouga et al., 2014) , affording a unique opportunity for the targeted delivery of cytotoxic compounds into cells. To further investigate the structure-activity relationship of the copper complexes of 5-pyridylmethylene-imidazole-4-ones we have synthesized a series of copper complexes based on the structurally similar 2-amino-imidazole-4-ones. In contrast to our previously reported ligands, these new systems contain a nitrogen substituent at the 2-position of their imidazoline ring instead of a sulfur atom. We have also prepared a series of structurally related cobalt(II) complexes of 5-pyridylmethylene-2-amino-imidazol-4-one ligands.
Experimental part

Materials and methods
All of the samples were prepared in reagent grade solvents. All of the chemicals used to synthesize the ligands were obtained from Acros or Sigma Aldrich and used as received without further purification. All of the reactions were monitored by thinlayer chromatography on Silufol precoated silica gel plates (with fluorescence indicator UV254) using a 1:1 (v/v) mixture of ethyl acetate and n-hexane as the solvent system. Melting point (mp) data were obtained in open capillaries on an SMP11 Stuart melting point apparatus and are uncorrected. Elemental analyses were conducted on a Vario MICRO cube CHNS/O Elementar system (Vario). 1 H and 13 C NMR spectra were recorded on a Bruker Avance 400 (400 MHz) spectrometer using CDCl 3 or (CD 3 ) 2 SO as a solvent. NMR data have been reported in the following order: chemical shift (d) value in ppm relative to the solvent resonance, which was used as an internal reference standard; and coupling constant (J) in Hertz (Hz). X-ray diffraction analysis was conducted on a CAD4 diffractometer at 293 K (graphite monochromated radiation, k (MoKa) = 0.71073 Å , x/1.33h scan type). The 2-methylthio-imidazole-4-one starting materials were synthesized according to previously published methods from the literature (Beloglazkina et al., 2005a,b; Majouga et al., 2004a, b; Majouga et al., 2014; Mironov et al., 2013) .
Electrochemical studies were carried out on a PI-50-1.1 potentiostat in MeCN. A 0.05 M solution of Bu 4 NClO 4 in MeCN was used as a supporting electrolyte, with Ag/AgCl/ KCl (saturated) as a reference electrode. All of these measurements were conducted under an atmosphere of argon. The samples were dissolved in previously de-aerated solvents.
2.2. Morpholine-substituted ligands 2.2.1. General procedure Morpholine (2 ml) and a catalytic amount of ytterbium(III) triflate (5 mol%) were added to 3-substituted-5-((Z)-2-pyridyl methylene)-2-methylthioimidazole-4-one. The reaction mixture was boiled until none of reagents were observed by TLC. The reaction mixture was evaporated to dryness, then EtOH (1 ml) was added and the obtained precipitate was filtered off and recrystallized from ethanol.
2.2.1.1.
(5Z)-3-phenyl-2-(morpholine-1-yl)-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one (1). The reaction of 0.207 g (0.7 mmol) (5Z)-3-phenyl-5-(2-pyridylmethy lene)-2-methylthiotetrahydro-4H-imidazole-4-one with morpholine yielded 0.118 g (50%) of compound 1. M. p. 223°C. (5Z)-3-methyl-2-(morpholine-1-yl)-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one (2). The reaction of 0.2 g (0.86 mmol) (5Z)-3-methyl-5-(2-pyridylmethy lene)-2-methylthiotetrahydro-4H-imidazole-4-one with morpholine yielded 0.150 g (64%) of compound 2. M. p. 155°C. (5Z)-3-allyl-2-(morpholine-1-yl)-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one (3). The reaction of 0.133 g (0.52 mmol) (5Z)-3-allyl-5-(2-pyridylmethy lene)-2-methylthiotetrahydro-4H-imidazole-4-one with morpholine yielded 0.11 g (71%) of compound 3. M. p. 148°C. Piperidine (4.3 ml) and a catalytic amount of ytterbium(III) triflate (5 mol%) were added to 3-substituted (5Z)-(5-pyridyl methylene)-2-methylthio-imidazole-4-one. The reaction mixture was boiled until none of starting reagents was seen on TLC. The reaction mixture was evaporated to dryness, then diethyl ether was added and the obtained precipitate was filtered off and recrystallized from ethanol. 
Coordination compounds
To the solution of ligand 1-8 in 1 ml of CH 2 Cl 2 the solution of equimolar amount of CuCl 2 Á2H 2 O or CoCl 2 Á6H 2 O in 1 ml of n-BuOH was carefully added and the mixture was left in a closed vessel until precipitation. The forming dark green crystals were filtered off and dried in air.
Complex 1a was obtained from 10 mg (0.03 mmol) of compound 1 and 5.3 mg (0.03 mmol) CuCl 2 Á2H 2 O. Yield 3 mg (22%). Elemental analysis: C 19 H 18 N 4 O 2 CuCl 2 calculated: C 48.67%, H 3.84%, N 11.95%; found: C 48.92%, H 3.80%, N 11.92%.
(5Z)-
Complex 2a was obtained from 10 mg (0.037 mmol) of compound 2 and 6.3 mg (0.037 mmol) CuCl 2 Á2H 2 O. Yield 3 mg (20%). Elemental analysis: C 14 H 16 N 4 O 2 CuCl 2 calculated: C 41.33%, H 3.94%, N 13.78%; found: C 41.50%, H 4.15%, N 13.56%.
Complex 3a was obtained from 10 mg (0.036 mmol) of compound 3 and 5.7 mg (0.036 mmol) CuCl 2 Á2H 2 O. Yield 3.9 mg (25%). Elemental analysis: C 16 H 18 N 4 O 2 CuCl 2 calculated: C 44.40%, H 4.19%, N 12.95%; found: C 44.26%, H 4.07%, N 13.07%. Novel 2-aminoimidazole-4-one complexes of copper(II) and cobalt(II)
Complex 5a was obtained from 20 mg (0.06 mmol) of compound 5 and 10.2 mg (0.059 mmol) CuCl 2 Á2H 2 O. Yield 7 mg (25%). Elemental analysis: C 20 H 20 N 4 OCuCl 2 calculated: C 51.44%, H 4.29%, N 12.00%; found: C 51.60%, H 4.22%, N 11.99%.
Complex 6a was obtained from 10 mg (0.037 mmol) of compound 6 and 8.8 mg (0.052 mmol) CuCl 2 Á2H 2 O. Yield 3.4 mg (22%). Elemental analysis: C 15 H 18 N 4 OCuCl 2 calculated: C 44.51%, H 4.48%, N 13.84%; found: C 44.39%, H 4.56%, N 13.89%.
Complex 7a was obtained from 10 mg (0.034 mmol) of compound 7 and 5.8 mg (0.034 mmol) CuCl 2 Á2H 2 O. Yield 3.7 mg (25%). Elemental analysis: C 17 H 20 N 4 OCuCl 2 calculated: C 47.39%, H 4.65%, N 13.01%; found: C 47.32%, H 4.57%, N 13.22%. 
3-(2-azidoethyl)-2-(piperidine-1-yl)-5-(pyridine-2- ylmethylene)-3,5-dihydro-4H-imidazole-4-one copper(II) dichloride (8a)
Complex 1b was obtained from 10 mg (0.03 mmol) of compound 1 and 7.2 mg (0.03 mmol) CoCl 2 Á6H 2 O. Yield 3.3 mg (24%). Elemental analysis: C 19 H 18 N 4 O 2 CoCl 2 calculated: C 49.15%, H 3.88%, N 12.08%; found: C 49.47 %, H 4.11 %, N 12.23%.
Complex 2b was obtained from 10 mg (0.037 mmol) of compound 2 and 8.8 mg (0.037 mmol) CoCl 2 Á6H 2 O. Yield 3.1 mg (21%). Elemental analysis: C 14 H 16 N 4 O 2 CoCl 2 calculated: C 41.79%, H 3.98%, N 13.93%; found: C 41.60%, H 3.76%, N 13.73%.
Yield 3.8 mg (24%). Complex 3b was obtained from 10 mg (0.036 mmol) of compound 3 and 8 mg (0.036 mmol) CoCl 2 -Á6H 2 O. Elemental analysis: C 16 H 18 N 4 O 2 CoCl 2 calculated: C 44.88%, H 4.24%, N 13.08%; found: C 45.11 %, H 4.40%, N 12.99%. 
3-(2-azidoethyl)-2-(morpholine-1-yl)-5-(pyridine- 2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one cobalt(II) dichloride (4b)
Results and discussion
Herein, we report the synthesis and characterization of a series of novel 2-aminosubstituted (5Z)-3-phenyl-5-(pyridine-2-ylme thylene)-3,5-dihydro-4H-imidazole-4-ones and their copper (II) and cobalt(II) complexes. These ligands varied in terms of the structure of their amine moiety (i.e., morpholine or piperidine), as well as the nature of the substituent on their N(3) atom (i.e., phenyl, methyl, allyl or 2-azidoethyl). It is noteworthy that all of these ligands contained an azide group, making their complexes amenable to the preparation of cova-lent conjugates with both low molecular weight compounds and biopolymers using ''click" chemistry.
Synthesis and characterization
The most commonly used approach for the synthesis to 2-amino-imidazole-4-ones involves the reaction of 2-thiohydantoins or their S-alkylated derivatives with an amine under heating (El-Barbary et al., 2000; Hu et al., 2002) or microwave irradiation (Asmaa et al., 2007) . It is noteworthy that S-alkylated thiohydantoins have been reported to show better results in these reactions than 2-thiohydantoins (Carver et al., 1997; Grimmet, 1970; Lindel and Hoffmann, 1997; Roue and Bergman, 1999; Ybrahim et al., 1980) . With this in mind, S-alkylated thiohydantoins were selected as starting materials for this study.
We initially investigated the reactions of 2-methylthiosubstituted imidazolones with morpholine under reflux conditions. However, these conditions failed to afford the desired 2-morpholyl-substituted imidazolones 5-7 in yields greater than 10%. To increase the yields of the target amino-imidazolones we investigated the use of several Lewis acid catalysts, including AlCl 3 , ZnCl 2 and Yb(OTf) 3 . The results revealed that AlCl 3 and ZnCl 2 did not catalyze the reaction, whereas the use of ytterbium(III) triflate led to a significant increase in the yields of the desired amino-substituted imidazolones to 46-82% (Scheme 1).
Compounds 3-6 were isolated as single geometric isomers, which were determined to the (Z)-isomers based on the chemical shifts and the coupling constants of the vinylic protons by 1 H NMR spectroscopy (Mironov et al., 2013) . The (Z)-configurations of ligands 2, 5 and 6 were also confirmed based on the X-ray diffraction analysis of the corresponding coordination complexes 2b, 5b and 6b (see below).
A series of Cu(II) and Co(II) complexes were prepared using the (5Z)-2-amino-5-(pyridine-2-ylmethylene)-3,5-dihy dro-4H-imidazole-4-ones prepared in the current study by the direct reaction of CH 2 Cl 2 solutions of these ligands with copper(II) or cobalt(II) chloride, respectively (Scheme 2). All of the resulting complexes were characterized by elemental analysis. The coordination compounds 1a-6a, 1b, 2b, 4b, 7b and 8b were also characterized by UV/Vis spectroscopy. Characteristic low-intensity d-d transition bands were observed in the UV/Vis spectra of all of the coordination compounds prepared in the current study in the range of 550-720 nm ( Fig. 1 and Supplementary information). These data were consistent with the literature data for the tetrahedral Cu(II) and Co(II) complexes of 2-substituted 5-pyridylmethylene-imidazol-4-on es (Beloglazkina et al., 2005a (Beloglazkina et al., ,b, 2006a Majouga et al., 2004a Majouga et al., ,b, 2009 Majouga et al., , 2014 . According to the literature (Guo et al., 2002; Rowland et al., 2000; Hennig et al., 1995 , and previous references), the UV/Vis spectra of square planar copper(II) complexes should contain a broad band in the range of 550-750 nm, which would show a bathochromic shift upon tetrahedral distortion. The UV/Vis spectra of square planar cobalt complexes normally contain only one band in the visible region, whereas tetrahedral Co(II) complexes generally give three bands (or a broad band, representing the superposition of two overlapping bands) in this region ( Van der Bergen et al., 1974; Beloglazkina et al., 2013) . All of the complexes prepared in the current study also exhibited strong charge transfer bands in the UV region of their electronic spectra (see Supplementary information).
Molecular structures of complexes 2b, 5b and 6d
The structures of complexes 2b, 5b and 6b were confirmed by X-ray diffraction analysis, and the crystal structures are shown in Fig. 2 . Selected bond lengths and bond angles from these crystal structures are shown in Tables 1 and 2 . The previously reported (Majouga et al., 2004a,b) crystal structure of the cobalt complex of (5Z)-3-phenyl-2-methylthio-5-(pyridine-2-y lmethylene)-3,5-dihydro-4H-imidazole-4-one (complex A) is also shown in Fig. 1 for the sake of comparison. All of the crystallographic data and refinement parameters are shown in Tables S1, together with a list of bond lengths and bond angles. The cobalt ions in all of these complexes were tetrahedrally coordinated to the two nitrogen atoms of the pyridine and thiohydantoin rings and two chloride anions. The cobalt atoms were located in a distorted tetrahedral environment with CoAN distances of 2.032-2.040(10) Ǻ (CoAN Py ) and 1.989-1.997(10) Ǻ (CoAN Im ), which were similar to those observed in complex A (Majouga et al., 2004a,b) . The phenyl substituent at the N(3) position of the ligand moiety in complex 5b was near perpendicular to the plane of the imidazolone ring. The piperidine and morpholine rings were found to exist in the chair conformations.
Scheme 1 Synthesis of (5Z)-2-amino-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-ones 1-8.
Novel 2-aminoimidazole-4-one complexes of copper(II) and cobalt(II)
Consideration of the data in Tables 1 and 2 revealed that while the differences in the CoAN and CoACl bond lengths of the complexes of the 2-amino-and 2-thio-substituted imidazole-4-ones were negligible, the Cl1ACoAN2 bond angles differed considerable in these complexes. The tetrahedral coordination environment of the cobalt ions in the amino-substituted ligand complexes (2b, 5b, 6b) underwent much less distortion than the corresponding sulfurcontaining (A) complexes. This difference was attributed to a higher level of steric hindrance around the metal ion of the 2-methylthio substituent compared with the corresponding 2-amino group.
Electrochemistry
Electrochemical studies were conducted using ligands 1, 2 and 7, together with their complexes, as representative examples by cyclic voltammetry (CV) using glassy carbon, platinum and gold electrodes. The results showed that all three of the ligands were reduced in two steps, the first of which was reversible with the second being irreversible (see Fig. 3 and Table 3 ). Ligand 1 bearing a phenyl substituent on its N(3) atom was reduced much more readily (i.e., 200 mV less cathodic) than the corresponding methyl-and allyl-substituted ligands 2 and 7, most likely because of the presence of the conjugated phenyl fragment.
The oxidation reactions of compounds 1, 2 and 7 revealed that ligand 1 was irreversibly oxidized in a single-electron process, whereas compounds 2 and 7 were irreversibly oxidized in a two-electron process (Table 3, Fig. 3) .
The cyclic voltammograms for cobalt complexes 1b and 2b contained additional peaks in the cathodic region for E pc values in the range of À0.89 to À1.0 V for all of the electrodes, corresponding to the reduction of Co(II) to Co(I) ( Table 3 , Scheme 2 Synthesis of copper(II) and cobalt(II) complexes of 2-amino-imidazole-4-ones 1-8. Figure 1 Electronic spectra of cobalt(II) complexes 2b, 4b, 5b, 7b and 8b, 550-800 nm (DMSO, 10 À4 M).
Figure 2 Molecular structures of coordination compounds 2b, 5b, 6b in comparison with the molecular structure of (5Z)-3-phenyl-2-methylthio-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one cobalt(II) dichloride A (Majouga et al., 2004a,b) . Cobalt ions are shown on blue, nitrogen atoms in light blue, chlorine atoms in green, oxygen atoms in red, and sulfur atom in yellow. Fig. 4) . The initial reduction of the cobalt complexes was found to be reversible at all of the electrodes. However, the intensity of the Co(II)/Co(I) re-oxidation peak for complex 2b was equal to about half of the reduction current over the Au and Pt electrodes. This result therefore suggested that the Co(I)-containing intermediates were stable on the timescale required for their analysis by CV, and that they were less stable on metal electrodes than the GC electrode. The other peaks observed in the cathode region for the Co complexes were attributed to the reduction of the ligand fragments. These peaks were shifted slightly for complexes 2b and 7b relative to the corresponding peaks of the ligand, with the shift for complex 1b being the greatest of all (approximately 200 mV). These results indicate that the complexation of the ligands with cobalt leads to a change in the mechanism with which the ligand moiety is oxidized. This was confirmed by the fact that the first anodic peak for the complexes was a two-electron process.
The copper-containing complexes 1a-3a were reversibly reduced at potentials (E pc ) in the range of 0.24-0.26 V (i.e., potentials around 200 mV). These potentials were less cathodic than those previously reported by our group for the thiohydantoin complexes of copper(II), which showed an E pc value of 0.45 V (Beloglazkina et al., 2005a) .
The cyclic voltammograms showed that there were no desorption peaks corresponding to zero-valent copper on the GC or Pt electrodes, even under the reverse potential scan conditions after the oxidation and reduction of the ligand fragments. This result therefore indicated that the Cu(I)-containing intermediates were stable as complexes with both negatively and positively charged ligands. However, sharp triangular peaks (without a diffusion loop) were observed at the Au electrode for the copper-containing complexes 1a and 2a after the oxidation or reduction of the ligand moiety (Fig. 5 ), which were characteristic for the desorption of metallic copper from the electrode surface. It is therefore possible that the reduction intermediates (i.e., complexes of the negatively charged ligand (L À ) with Cu(I)) could be unstable and disproportionate to give Cu(II) and Cu(0) complexes, with the latter of these two complexes decomposing with the release of metallic copper:
In contrast, any complexes formed with the positively charged ligands would be oxidized because of the low donor ability of the cationic ligand fragments.
It is noteworthy that no desorption peaks were observed for cycling potentials in the range of 0.1-0.65 V, which indicated the cobalt(I) complex formed with the neutral ligand was stable under these conditions.
Cytotoxicity
The ligands and the corresponding copper and cobalt complexes prepared in the current study were tested in terms of their in vitro cytotoxicity against cell cancer cells lines, including human lung cancer (A549), breast adenocarcinoma (MCF-7) and human embryonic kidney (HEK293) cells using a standard MTT assay (Mosmann, 1983) . The results of this assay are shown in Table 4 together with the results obtained for the clinically used drugs cisplatin and doxorubicin, which have been included for comparison.
The coordination of a metal ion was found to be essential for the cytotoxicity of the test compounds. For example, the IC 50 values of the free ligands were much higher than those of the corresponding copper complexes. However, the cytotoxicities of the cobalt complexes were substantially lower than those of the corresponding copper complexes, although in some cases they were higher than those of the free ligands. The nature of the amine substituent at the 2 position of the imidazolone ring was also found to be important to the cytotoxicity of these compounds. For example, compounds containing a piperidine substituent (i.e., 5-7) were generally 1.5-2 times more active than compounds containing a morpholine residue at the same position (i.e., 1-3). The nature of the substituent at the N(3) position of the imidazolone ring also had a considerable impact on the cytotoxicity, which increased in the order Ph > Allyl > Me. This increase in the cytotoxicity correlates well with the increasing lipophilicity of the complexes.
HEK293 cells were found to be the most vulnerable of all the cell lines tested in the current study toward the test compounds, with complex 5a showing the greatest cytotoxicity of all of the test complexes. Furthermore, the cytotoxicity of complex 5a toward HEK293 cells was similar to that of cisplatin. The most active cobalt complexes were found to be compounds 1b and 7b. The cytotoxicities of these complexes toward MCF7 cells were 1.5 times greater than those of cisplatin.
Although the generation of reactive oxygen species (ROS) has been cited as a major contributory factor to the high tox- icity and anticancer activity of numerous copper complexes (Hajrezaie et al., 2014; Mookerjee et al., 2006; Ng et al., 2014; Guo et al., 2010; Maheswari et al., 2008) , we have assumed that the compounds described in this study do not induce the generation of ROS. This suggestion is supported by the lack of a correlation between the reduction potentials of these compounds and their cytotoxicity. All of the complexes prepared in the current study showed relatively low reduction potentials compared with those reported in our previous studies (Majouga et al., 2014) , where we observed potentials around 0.45 V for the copper complexes of 2-thiohydantoin. The facile reduction of these complexes would Novel 2-aminoimidazole-4-one complexes of copper(II) and cobalt(II)facilitate their interaction with oxygen, which would enhance their cytotoxicity. However, this outcome was not observed, which suggested that the complexes prepared in the current study exert their cytotoxicity through a different mechanism.
Conclusions
In conclusion, we have prepared a novel series of nitrogen-containing bidentate organic ligands, together with their corresponding copper and cobalt complexes. These compounds have been fully characterized based on their NMR, IR, UV/Vis, elemental analysis and cyclic voltammetry data. Three cobalt complexes were also characterized by single-crystal X-ray analysis. The cytotoxicities of the copper containing complexes were comparable to those of cisplatin and doxorubicin against MCF-7, A549 and HEK293 cells. In contrast to many of other well-known metal-containing drugs, the mechanism of action of these complexes does not appear to include the formation of ROS.
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